Global Post-traumatic Stress Disorder Treatment Drug Market Research Report 2024

Post-traumatic Stress Disorder Treatment Drug Market

The global Post-traumatic Stress Disorder Treatment Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Post-traumatic Stress Disorder Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Post-traumatic Stress Disorder Treatment Drug.

Report Scope

The Post-traumatic Stress Disorder Treatment Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Post-traumatic Stress Disorder Treatment Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Post-traumatic Stress Disorder Treatment Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Jazz Pharmaceuticals plc.

Madrigal Mental Care

Allergan PLC

Otsuka Pharmaceutical Co., Ltd.

apex laboratories Pvt. Ltd.

H. Lundbeck A/S（Lundbeck）

Neurovation Labs, Inc.

Eli Lilly and Company

GlaxoSmithKline PLC

Sun Pharmaceuticals Pvt Ltd

Bristol-Myers Squibb

Johnson and Johnson

Pfizer Inc.

Aurobindo Inc.

Amneal Pharmaceuticals LLC

Teva Pharmaceuticals Industries Ltd.

Mylan Pharmaceuticals（Viatris Inc.）

Oral Administration

Parenteral Administration

Nasal Administration

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Scope of Post-traumatic Stress Disorder Treatment Drug Market Report

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Post-traumatic Stress Disorder Treatment Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Post-traumatic Stress Disorder Treatment Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Oral Administration

1.2.3 Parenteral Administration

1.2.4 Nasal Administration

1.3 Market by Application

1.3.1 Global Post-traumatic Stress Disorder Treatment Drug Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Post-traumatic Stress Disorder Treatment Drug Market Perspective (2019-2030)

2.2 Post-traumatic Stress Disorder Treatment Drug Growth Trends by Region

2.2.1 Global Post-traumatic Stress Disorder Treatment Drug Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Post-traumatic Stress Disorder Treatment Drug Historic Market Size by Region (2019-2024)

2.2.3 Post-traumatic Stress Disorder Treatment Drug Forecasted Market Size by Region (2025-2030)

2.3 Post-traumatic Stress Disorder Treatment Drug Market Dynamics

2.3.1 Post-traumatic Stress Disorder Treatment Drug Industry Trends

2.3.2 Post-traumatic Stress Disorder Treatment Drug Market Drivers

2.3.3 Post-traumatic Stress Disorder Treatment Drug Market Challenges

2.3.4 Post-traumatic Stress Disorder Treatment Drug Market Restraints

3.1 Global Top Post-traumatic Stress Disorder Treatment Drug Players by Revenue

3.1.1 Global Top Post-traumatic Stress Disorder Treatment Drug Players by Revenue (2019-2024)

3.1.2 Global Post-traumatic Stress Disorder Treatment Drug Revenue Market Share by Players (2019-2024)

3.2 Global Post-traumatic Stress Disorder Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Post-traumatic Stress Disorder Treatment Drug Revenue

3.4 Global Post-traumatic Stress Disorder Treatment Drug Market Concentration Ratio

3.4.1 Global Post-traumatic Stress Disorder Treatment Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Post-traumatic Stress Disorder Treatment Drug Revenue in 2023

3.5 Post-traumatic Stress Disorder Treatment Drug Key Players Head office and Area Served

3.6 Key Players Post-traumatic Stress Disorder Treatment Drug Product Solution and Service

3.7 Date of Enter into Post-traumatic Stress Disorder Treatment Drug Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Post-traumatic Stress Disorder Treatment Drug Historic Market Size by Type (2019-2024)

4.2 Global Post-traumatic Stress Disorder Treatment Drug Forecasted Market Size by Type (2025-2030)

5.1 Global Post-traumatic Stress Disorder Treatment Drug Historic Market Size by Application (2019-2024)

5.2 Global Post-traumatic Stress Disorder Treatment Drug Forecasted Market Size by Application (2025-2030)

6.1 North America Post-traumatic Stress Disorder Treatment Drug Market Size (2019-2030)

6.2 North America Post-traumatic Stress Disorder Treatment Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Post-traumatic Stress Disorder Treatment Drug Market Size by Country (2019-2024)

6.4 North America Post-traumatic Stress Disorder Treatment Drug Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7.1 Europe Post-traumatic Stress Disorder Treatment Drug Market Size (2019-2030)

7.2 Europe Post-traumatic Stress Disorder Treatment Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Post-traumatic Stress Disorder Treatment Drug Market Size by Country (2019-2024)

7.4 Europe Post-traumatic Stress Disorder Treatment Drug Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Post-traumatic Stress Disorder Treatment Drug Market Size (2019-2030)

8.2 Asia-Pacific Post-traumatic Stress Disorder Treatment Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Post-traumatic Stress Disorder Treatment Drug Market Size by Region (2019-2024)

8.4 Asia-Pacific Post-traumatic Stress Disorder Treatment Drug Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Post-traumatic Stress Disorder Treatment Drug Market Size (2019-2030)

9.2 Latin America Post-traumatic Stress Disorder Treatment Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Post-traumatic Stress Disorder Treatment Drug Market Size by Country (2019-2024)

9.4 Latin America Post-traumatic Stress Disorder Treatment Drug Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Post-traumatic Stress Disorder Treatment Drug Market Size (2019-2030)

10.2 Middle East & Africa Post-traumatic Stress Disorder Treatment Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Post-traumatic Stress Disorder Treatment Drug Market Size by Country (2019-2024)

10.4 Middle East & Africa Post-traumatic Stress Disorder Treatment Drug Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Jazz Pharmaceuticals plc.

11.1.1 Jazz Pharmaceuticals plc. Company Detail

11.1.2 Jazz Pharmaceuticals plc. Business Overview

11.1.3 Jazz Pharmaceuticals plc. Post-traumatic Stress Disorder Treatment Drug Introduction

11.1.4 Jazz Pharmaceuticals plc. Revenue in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024)

11.1.5 Jazz Pharmaceuticals plc. Recent Development

11.2 Madrigal Mental Care

11.2.1 Madrigal Mental Care Company Detail

11.2.2 Madrigal Mental Care Business Overview

11.2.3 Madrigal Mental Care Post-traumatic Stress Disorder Treatment Drug Introduction

11.2.4 Madrigal Mental Care Revenue in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024)

11.2.5 Madrigal Mental Care Recent Development

11.3 Allergan PLC

11.3.1 Allergan PLC Company Detail

11.3.2 Allergan PLC Business Overview

11.3.3 Allergan PLC Post-traumatic Stress Disorder Treatment Drug Introduction

11.3.4 Allergan PLC Revenue in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024)

11.3.5 Allergan PLC Recent Development

11.4 Otsuka Pharmaceutical Co., Ltd.

11.4.1 Otsuka Pharmaceutical Co., Ltd. Company Detail

11.4.2 Otsuka Pharmaceutical Co., Ltd. Business Overview

11.4.3 Otsuka Pharmaceutical Co., Ltd. Post-traumatic Stress Disorder Treatment Drug Introduction

11.4.4 Otsuka Pharmaceutical Co., Ltd. Revenue in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024)

11.4.5 Otsuka Pharmaceutical Co., Ltd. Recent Development

11.5 apex laboratories Pvt. Ltd.

11.5.1 apex laboratories Pvt. Ltd. Company Detail

11.5.2 apex laboratories Pvt. Ltd. Business Overview

11.5.3 apex laboratories Pvt. Ltd. Post-traumatic Stress Disorder Treatment Drug Introduction

11.5.4 apex laboratories Pvt. Ltd. Revenue in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024)

11.5.5 apex laboratories Pvt. Ltd. Recent Development

11.6 H. Lundbeck A/S（Lundbeck）

11.6.1 H. Lundbeck A/S（Lundbeck） Company Detail

11.6.2 H. Lundbeck A/S（Lundbeck） Business Overview

11.6.3 H. Lundbeck A/S（Lundbeck） Post-traumatic Stress Disorder Treatment Drug Introduction

11.6.4 H. Lundbeck A/S（Lundbeck） Revenue in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024)

11.6.5 H. Lundbeck A/S（Lundbeck） Recent Development

11.7 Neurovation Labs, Inc.

11.7.1 Neurovation Labs, Inc. Company Detail

11.7.2 Neurovation Labs, Inc. Business Overview

11.7.3 Neurovation Labs, Inc. Post-traumatic Stress Disorder Treatment Drug Introduction

11.7.4 Neurovation Labs, Inc. Revenue in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024)

11.7.5 Neurovation Labs, Inc. Recent Development

11.8 Eli Lilly and Company

11.8.1 Eli Lilly and Company Company Detail

11.8.2 Eli Lilly and Company Business Overview

11.8.3 Eli Lilly and Company Post-traumatic Stress Disorder Treatment Drug Introduction

11.8.4 Eli Lilly and Company Revenue in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024)

11.8.5 Eli Lilly and Company Recent Development

11.9 GlaxoSmithKline PLC

11.9.1 GlaxoSmithKline PLC Company Detail

11.9.2 GlaxoSmithKline PLC Business Overview

11.9.3 GlaxoSmithKline PLC Post-traumatic Stress Disorder Treatment Drug Introduction

11.9.4 GlaxoSmithKline PLC Revenue in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024)

11.9.5 GlaxoSmithKline PLC Recent Development

11.10 Sun Pharmaceuticals Pvt Ltd

11.10.1 Sun Pharmaceuticals Pvt Ltd Company Detail

11.10.2 Sun Pharmaceuticals Pvt Ltd Business Overview

11.10.3 Sun Pharmaceuticals Pvt Ltd Post-traumatic Stress Disorder Treatment Drug Introduction

11.10.4 Sun Pharmaceuticals Pvt Ltd Revenue in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024)

11.10.5 Sun Pharmaceuticals Pvt Ltd Recent Development

11.11 Bristol-Myers Squibb

11.11.1 Bristol-Myers Squibb Company Detail

11.11.2 Bristol-Myers Squibb Business Overview

11.11.3 Bristol-Myers Squibb Post-traumatic Stress Disorder Treatment Drug Introduction

11.11.4 Bristol-Myers Squibb Revenue in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024)

11.11.5 Bristol-Myers Squibb Recent Development

11.12 Johnson and Johnson

11.12.1 Johnson and Johnson Company Detail

11.12.2 Johnson and Johnson Business Overview

11.12.3 Johnson and Johnson Post-traumatic Stress Disorder Treatment Drug Introduction

11.12.4 Johnson and Johnson Revenue in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024)

11.12.5 Johnson and Johnson Recent Development

11.13 Pfizer Inc.

11.13.1 Pfizer Inc. Company Detail

11.13.2 Pfizer Inc. Business Overview

11.13.3 Pfizer Inc. Post-traumatic Stress Disorder Treatment Drug Introduction

11.13.4 Pfizer Inc. Revenue in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024)

11.13.5 Pfizer Inc. Recent Development

11.14 Aurobindo Inc.

11.14.1 Aurobindo Inc. Company Detail

11.14.2 Aurobindo Inc. Business Overview

11.14.3 Aurobindo Inc. Post-traumatic Stress Disorder Treatment Drug Introduction

11.14.4 Aurobindo Inc. Revenue in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024)

11.14.5 Aurobindo Inc. Recent Development

11.15 Amneal Pharmaceuticals LLC

11.15.1 Amneal Pharmaceuticals LLC Company Detail

11.15.2 Amneal Pharmaceuticals LLC Business Overview

11.15.3 Amneal Pharmaceuticals LLC Post-traumatic Stress Disorder Treatment Drug Introduction

11.15.4 Amneal Pharmaceuticals LLC Revenue in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024)

11.15.5 Amneal Pharmaceuticals LLC Recent Development

11.16 Teva Pharmaceuticals Industries Ltd.

11.16.1 Teva Pharmaceuticals Industries Ltd. Company Detail

11.16.2 Teva Pharmaceuticals Industries Ltd. Business Overview

11.16.3 Teva Pharmaceuticals Industries Ltd. Post-traumatic Stress Disorder Treatment Drug Introduction

11.16.4 Teva Pharmaceuticals Industries Ltd. Revenue in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024)

11.16.5 Teva Pharmaceuticals Industries Ltd. Recent Development

11.17 Mylan Pharmaceuticals（Viatris Inc.）

11.17.1 Mylan Pharmaceuticals（Viatris Inc.） Company Detail

11.17.2 Mylan Pharmaceuticals（Viatris Inc.） Business Overview

11.17.3 Mylan Pharmaceuticals（Viatris Inc.） Post-traumatic Stress Disorder Treatment Drug Introduction

11.17.4 Mylan Pharmaceuticals（Viatris Inc.） Revenue in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024)

11.17.5 Mylan Pharmaceuticals（Viatris Inc.） Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Post-traumatic Stress Disorder Treatment Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

    Table 2. Key Players of Oral Administration

    Table 3. Key Players of Parenteral Administration

    Table 4. Key Players of Nasal Administration

    Table 5. Global Post-traumatic Stress Disorder Treatment Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

    Table 6. Global Post-traumatic Stress Disorder Treatment Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

    Table 7. Global Post-traumatic Stress Disorder Treatment Drug Market Size by Region (2019-2024) & (US$ Million)

    Table 8. Global Post-traumatic Stress Disorder Treatment Drug Market Share by Region (2019-2024)

    Table 9. Global Post-traumatic Stress Disorder Treatment Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)

    Table 10. Global Post-traumatic Stress Disorder Treatment Drug Market Share by Region (2025-2030)

    Table 11. Post-traumatic Stress Disorder Treatment Drug Market Trends

    Table 12. Post-traumatic Stress Disorder Treatment Drug Market Drivers

    Table 13. Post-traumatic Stress Disorder Treatment Drug Market Challenges

    Table 14. Post-traumatic Stress Disorder Treatment Drug Market Restraints

    Table 15. Global Post-traumatic Stress Disorder Treatment Drug Revenue by Players (2019-2024) & (US$ Million)

    Table 16. Global Post-traumatic Stress Disorder Treatment Drug Market Share by Players (2019-2024)

    Table 17. Global Top Post-traumatic Stress Disorder Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post-traumatic Stress Disorder Treatment Drug as of 2023)

    Table 18. Ranking of Global Top Post-traumatic Stress Disorder Treatment Drug Companies by Revenue (US$ Million) in 2023

    Table 19. Global 5 Largest Players Market Share by Post-traumatic Stress Disorder Treatment Drug Revenue (CR5 and HHI) & (2019-2024)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players Post-traumatic Stress Disorder Treatment Drug Product Solution and Service

    Table 22. Date of Enter into Post-traumatic Stress Disorder Treatment Drug Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Post-traumatic Stress Disorder Treatment Drug Market Size by Type (2019-2024) & (US$ Million)

    Table 25. Global Post-traumatic Stress Disorder Treatment Drug Revenue Market Share by Type (2019-2024)

    Table 26. Global Post-traumatic Stress Disorder Treatment Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)

    Table 27. Global Post-traumatic Stress Disorder Treatment Drug Revenue Market Share by Type (2025-2030)

    Table 28. Global Post-traumatic Stress Disorder Treatment Drug Market Size by Application (2019-2024) & (US$ Million)

    Table 29. Global Post-traumatic Stress Disorder Treatment Drug Revenue Market Share by Application (2019-2024)

    Table 30. Global Post-traumatic Stress Disorder Treatment Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)

    Table 31. Global Post-traumatic Stress Disorder Treatment Drug Revenue Market Share by Application (2025-2030)

    Table 32. North America Post-traumatic Stress Disorder Treatment Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 33. North America Post-traumatic Stress Disorder Treatment Drug Market Size by Country (2019-2024) & (US$ Million)

    Table 34. North America Post-traumatic Stress Disorder Treatment Drug Market Size by Country (2025-2030) & (US$ Million)

    Table 35. Europe Post-traumatic Stress Disorder Treatment Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 36. Europe Post-traumatic Stress Disorder Treatment Drug Market Size by Country (2019-2024) & (US$ Million)

    Table 37. Europe Post-traumatic Stress Disorder Treatment Drug Market Size by Country (2025-2030) & (US$ Million)

    Table 38. Asia-Pacific Post-traumatic Stress Disorder Treatment Drug Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

    Table 39. Asia-Pacific Post-traumatic Stress Disorder Treatment Drug Market Size by Region (2019-2024) & (US$ Million)

    Table 40. Asia-Pacific Post-traumatic Stress Disorder Treatment Drug Market Size by Region (2025-2030) & (US$ Million)

    Table 41. Latin America Post-traumatic Stress Disorder Treatment Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 42. Latin America Post-traumatic Stress Disorder Treatment Drug Market Size by Country (2019-2024) & (US$ Million)

    Table 43. Latin America Post-traumatic Stress Disorder Treatment Drug Market Size by Country (2025-2030) & (US$ Million)

    Table 44. Middle East & Africa Post-traumatic Stress Disorder Treatment Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 45. Middle East & Africa Post-traumatic Stress Disorder Treatment Drug Market Size by Country (2019-2024) & (US$ Million)

    Table 46. Middle East & Africa Post-traumatic Stress Disorder Treatment Drug Market Size by Country (2025-2030) & (US$ Million)

    Table 47. Jazz Pharmaceuticals plc. Company Detail

    Table 48. Jazz Pharmaceuticals plc. Business Overview

    Table 49. Jazz Pharmaceuticals plc. Post-traumatic Stress Disorder Treatment Drug Product

    Table 50. Jazz Pharmaceuticals plc. Revenue in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024) & (US$ Million)

    Table 51. Jazz Pharmaceuticals plc. Recent Development

    Table 52. Madrigal Mental Care Company Detail

    Table 53. Madrigal Mental Care Business Overview

    Table 54. Madrigal Mental Care Post-traumatic Stress Disorder Treatment Drug Product

    Table 55. Madrigal Mental Care Revenue in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024) & (US$ Million)

    Table 56. Madrigal Mental Care Recent Development

    Table 57. Allergan PLC Company Detail

    Table 58. Allergan PLC Business Overview

    Table 59. Allergan PLC Post-traumatic Stress Disorder Treatment Drug Product

    Table 60. Allergan PLC Revenue in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024) & (US$ Million)

    Table 61. Allergan PLC Recent Development

    Table 62. Otsuka Pharmaceutical Co., Ltd. Company Detail

    Table 63. Otsuka Pharmaceutical Co., Ltd. Business Overview

    Table 64. Otsuka Pharmaceutical Co., Ltd. Post-traumatic Stress Disorder Treatment Drug Product

    Table 65. Otsuka Pharmaceutical Co., Ltd. Revenue in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024) & (US$ Million)

    Table 66. Otsuka Pharmaceutical Co., Ltd. Recent Development

    Table 67. apex laboratories Pvt. Ltd. Company Detail

    Table 68. apex laboratories Pvt. Ltd. Business Overview

    Table 69. apex laboratories Pvt. Ltd. Post-traumatic Stress Disorder Treatment Drug Product

    Table 70. apex laboratories Pvt. Ltd. Revenue in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024) & (US$ Million)

    Table 71. apex laboratories Pvt. Ltd. Recent Development

    Table 72. H. Lundbeck A/S（Lundbeck） Company Detail

    Table 73. H. Lundbeck A/S（Lundbeck） Business Overview

    Table 74. H. Lundbeck A/S（Lundbeck） Post-traumatic Stress Disorder Treatment Drug Product

    Table 75. H. Lundbeck A/S（Lundbeck） Revenue in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024) & (US$ Million)

    Table 76. H. Lundbeck A/S（Lundbeck） Recent Development

    Table 77. Neurovation Labs, Inc. Company Detail

    Table 78. Neurovation Labs, Inc. Business Overview

    Table 79. Neurovation Labs, Inc. Post-traumatic Stress Disorder Treatment Drug Product

    Table 80. Neurovation Labs, Inc. Revenue in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024) & (US$ Million)

    Table 81. Neurovation Labs, Inc. Recent Development

    Table 82. Eli Lilly and Company Company Detail

    Table 83. Eli Lilly and Company Business Overview

    Table 84. Eli Lilly and Company Post-traumatic Stress Disorder Treatment Drug Product

    Table 85. Eli Lilly and Company Revenue in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024) & (US$ Million)

    Table 86. Eli Lilly and Company Recent Development

    Table 87. GlaxoSmithKline PLC Company Detail

    Table 88. GlaxoSmithKline PLC Business Overview

    Table 89. GlaxoSmithKline PLC Post-traumatic Stress Disorder Treatment Drug Product

    Table 90. GlaxoSmithKline PLC Revenue in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024) & (US$ Million)

    Table 91. GlaxoSmithKline PLC Recent Development

    Table 92. Sun Pharmaceuticals Pvt Ltd Company Detail

    Table 93. Sun Pharmaceuticals Pvt Ltd Business Overview

    Table 94. Sun Pharmaceuticals Pvt Ltd Post-traumatic Stress Disorder Treatment Drug Product

    Table 95. Sun Pharmaceuticals Pvt Ltd Revenue in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024) & (US$ Million)

    Table 96. Sun Pharmaceuticals Pvt Ltd Recent Development

    Table 97. Bristol-Myers Squibb Company Detail

    Table 98. Bristol-Myers Squibb Business Overview

    Table 99. Bristol-Myers Squibb Post-traumatic Stress Disorder Treatment Drug Product

    Table 100. Bristol-Myers Squibb Revenue in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024) & (US$ Million)

    Table 101. Bristol-Myers Squibb Recent Development

    Table 102. Johnson and Johnson Company Detail

    Table 103. Johnson and Johnson Business Overview

    Table 104. Johnson and Johnson Post-traumatic Stress Disorder Treatment Drug Product

    Table 105. Johnson and Johnson Revenue in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024) & (US$ Million)

    Table 106. Johnson and Johnson Recent Development

    Table 107. Pfizer Inc. Company Detail

    Table 108. Pfizer Inc. Business Overview

    Table 109. Pfizer Inc. Post-traumatic Stress Disorder Treatment Drug Product

    Table 110. Pfizer Inc. Revenue in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024) & (US$ Million)

    Table 111. Pfizer Inc. Recent Development

    Table 112. Aurobindo Inc. Company Detail

    Table 113. Aurobindo Inc. Business Overview

    Table 114. Aurobindo Inc. Post-traumatic Stress Disorder Treatment Drug Product

    Table 115. Aurobindo Inc. Revenue in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024) & (US$ Million)

    Table 116. Aurobindo Inc. Recent Development

    Table 117. Amneal Pharmaceuticals LLC Company Detail

    Table 118. Amneal Pharmaceuticals LLC Business Overview

    Table 119. Amneal Pharmaceuticals LLC Post-traumatic Stress Disorder Treatment Drug Product

    Table 120. Amneal Pharmaceuticals LLC Revenue in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024) & (US$ Million)

    Table 121. Amneal Pharmaceuticals LLC Recent Development

    Table 122. Teva Pharmaceuticals Industries Ltd. Company Detail

    Table 123. Teva Pharmaceuticals Industries Ltd. Business Overview

    Table 124. Teva Pharmaceuticals Industries Ltd. Post-traumatic Stress Disorder Treatment Drug Product

    Table 125. Teva Pharmaceuticals Industries Ltd. Revenue in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024) & (US$ Million)

    Table 126. Teva Pharmaceuticals Industries Ltd. Recent Development

    Table 127. Mylan Pharmaceuticals（Viatris Inc.） Company Detail

    Table 128. Mylan Pharmaceuticals（Viatris Inc.） Business Overview

    Table 129. Mylan Pharmaceuticals（Viatris Inc.） Post-traumatic Stress Disorder Treatment Drug Product

    Table 130. Mylan Pharmaceuticals（Viatris Inc.） Revenue in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024) & (US$ Million)

    Table 131. Mylan Pharmaceuticals（Viatris Inc.） Recent Development

    Table 132. Research Programs/Design for This Report

    Table 133. Key Data Information from Secondary Sources

    Table 134. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Post-traumatic Stress Disorder Treatment Drug Market Size Comparison by Type (2024-2030) & (US$ Million)

    Figure 2. Global Post-traumatic Stress Disorder Treatment Drug Market Share by Type: 2023 VS 2030

    Figure 3. Oral Administration Features

    Figure 4. Parenteral Administration Features

    Figure 5. Nasal Administration Features

    Figure 6. Global Post-traumatic Stress Disorder Treatment Drug Market Size Comparison by Application (2024-2030) & (US$ Million)

    Figure 7. Global Post-traumatic Stress Disorder Treatment Drug Market Share by Application: 2023 VS 2030

    Figure 8. Hospital Pharmacies Case Studies

    Figure 9. Retail Pharmacies Case Studies

    Figure 10. Online Pharmacies Case Studies

    Figure 11. Post-traumatic Stress Disorder Treatment Drug Report Years Considered

    Figure 12. Global Post-traumatic Stress Disorder Treatment Drug Market Size (US$ Million), Year-over-Year: 2019-2030

    Figure 13. Global Post-traumatic Stress Disorder Treatment Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030

    Figure 14. Global Post-traumatic Stress Disorder Treatment Drug Market Share by Region: 2023 VS 2030

    Figure 15. Global Post-traumatic Stress Disorder Treatment Drug Market Share by Players in 2023

    Figure 16. Global Top Post-traumatic Stress Disorder Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post-traumatic Stress Disorder Treatment Drug as of 2023)

    Figure 17. The Top 10 and 5 Players Market Share by Post-traumatic Stress Disorder Treatment Drug Revenue in 2023

    Figure 18. North America Post-traumatic Stress Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 19. North America Post-traumatic Stress Disorder Treatment Drug Market Share by Country (2019-2030)

    Figure 20. United States Post-traumatic Stress Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 21. Canada Post-traumatic Stress Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 22. Europe Post-traumatic Stress Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 23. Europe Post-traumatic Stress Disorder Treatment Drug Market Share by Country (2019-2030)

    Figure 24. Germany Post-traumatic Stress Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 25. France Post-traumatic Stress Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 26. U.K. Post-traumatic Stress Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 27. Italy Post-traumatic Stress Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 28. Russia Post-traumatic Stress Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 29. Nordic Countries Post-traumatic Stress Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 30. Asia-Pacific Post-traumatic Stress Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 31. Asia-Pacific Post-traumatic Stress Disorder Treatment Drug Market Share by Region (2019-2030)

    Figure 32. China Post-traumatic Stress Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 33. Japan Post-traumatic Stress Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 34. South Korea Post-traumatic Stress Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 35. Southeast Asia Post-traumatic Stress Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 36. India Post-traumatic Stress Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 37. Australia Post-traumatic Stress Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 38. Latin America Post-traumatic Stress Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 39. Latin America Post-traumatic Stress Disorder Treatment Drug Market Share by Country (2019-2030)

    Figure 40. Mexico Post-traumatic Stress Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 41. Brazil Post-traumatic Stress Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 42. Middle East & Africa Post-traumatic Stress Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 43. Middle East & Africa Post-traumatic Stress Disorder Treatment Drug Market Share by Country (2019-2030)

    Figure 44. Turkey Post-traumatic Stress Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 45. Saudi Arabia Post-traumatic Stress Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 46. Jazz Pharmaceuticals plc. Revenue Growth Rate in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024)

    Figure 47. Madrigal Mental Care Revenue Growth Rate in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024)

    Figure 48. Allergan PLC Revenue Growth Rate in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024)

    Figure 49. Otsuka Pharmaceutical Co., Ltd. Revenue Growth Rate in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024)

    Figure 50. apex laboratories Pvt. Ltd. Revenue Growth Rate in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024)

    Figure 51. H. Lundbeck A/S（Lundbeck） Revenue Growth Rate in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024)

    Figure 52. Neurovation Labs, Inc. Revenue Growth Rate in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024)

    Figure 53. Eli Lilly and Company Revenue Growth Rate in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024)

    Figure 54. GlaxoSmithKline PLC Revenue Growth Rate in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024)

    Figure 55. Sun Pharmaceuticals Pvt Ltd Revenue Growth Rate in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024)

    Figure 56. Bristol-Myers Squibb Revenue Growth Rate in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024)

    Figure 57. Johnson and Johnson Revenue Growth Rate in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024)

    Figure 58. Pfizer Inc. Revenue Growth Rate in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024)

    Figure 59. Aurobindo Inc. Revenue Growth Rate in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024)

    Figure 60. Amneal Pharmaceuticals LLC Revenue Growth Rate in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024)

    Figure 61. Teva Pharmaceuticals Industries Ltd. Revenue Growth Rate in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024)

    Figure 62. Mylan Pharmaceuticals（Viatris Inc.） Revenue Growth Rate in Post-traumatic Stress Disorder Treatment Drug Business (2019-2024)

    Figure 63. Bottom-up and Top-down Approaches for This Report

    Figure 64. Data Triangulation

    Figure 65. Key Executives Interviewed